SWFI for Reconstitution of Lyophilized Drugs Market

Sterile Water for Injection (SWFI) is sterile, nonpyrogenic, distilled water in a single dose container for intravenous administration after addition of a suitable solute. It may also be used as a dispensing container for diluent use.
SWFI are used for reconstitution of lyophilized drugs, diluent of injection solution and rinsing agent for endoscopy in various departments. SWFI for reconstitution of lyophilized drugs.
In SWFI for Reconstitution of Lyophilized Drugs Market , we only collect data of SWFI being sold as a part of set with LYO drug.
SWFI for Reconstitution of Lyophilized Drugs Market contains market size and forecasts of SWFI for Reconstitution of Lyophilized Drugs in global, including the following market information:
Global SWFI for Reconstitution of Lyophilized Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global SWFI for Reconstitution of Lyophilized Drugs Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five SWFI for Reconstitution of Lyophilized Drugs companies in 2021 (%)
The global SWFI for Reconstitution of Lyophilized Drugs market was valued at 13 million in 2021 and is projected to reach US$ 19 million by 2028, at a CAGR of 5.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vials and Ampoules Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of SWFI for Reconstitution of Lyophilized Drugs include Baxter, Hospira (ICU Medical), Vetter, Otsuka, ROVI, Fresenius Kabi, Shijiazhuang No. 4 Pharmaceutical, Hikma and Kelun and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the SWFI for Reconstitution of Lyophilized Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global SWFI for Reconstitution of Lyophilized Drugs Market, by Container, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global SWFI for Reconstitution of Lyophilized Drugs Market Segment Percentages, by Container, 2021 (%)
Vials and Ampoules
Pre-Filled Syringes
Global SWFI for Reconstitution of Lyophilized Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global SWFI for Reconstitution of Lyophilized Drugs Market Segment Percentages, by Application, 2021 (%)
Vaccine
Biological Products
Bio-Pharmaceutical
Global SWFI for Reconstitution of Lyophilized Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global SWFI for Reconstitution of Lyophilized Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies SWFI for Reconstitution of Lyophilized Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies SWFI for Reconstitution of Lyophilized Drugs revenues share in global market, 2021 (%)
Key companies SWFI for Reconstitution of Lyophilized Drugs sales in global market, 2017-2022 (Estimated), (M Units)
Key companies SWFI for Reconstitution of Lyophilized Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Hospira (ICU Medical)
Vetter
Otsuka
ROVI
Fresenius Kabi
Shijiazhuang No. 4 Pharmaceutical
Hikma
Kelun
Deo Gratias Parenteral